Clorazepate (or TRANXENE®) is mainly prescribed to treat epilepsy, anxiety disorders, sleep disorders, and alcohol withdrawal syndrome.
FDA Approval: 1987
Dosage Forms: 3.75 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg, 50 mg
Biological Half-life: 48 hours
Side Effects: Dizziness, sleepiness, ataxia, confusion, anterograde amnesia, poor concentration, lack of coordination
Routes of Administration: Oral
Pregnancy Category: D (US)